Travere Therapeutics, Inc. (TVTX)
27.86
-1.07
(-3.70%)
USD |
NASDAQ |
Jan 15, 09:54
Travere Therapeutics Research and Development Expense (Quarterly): 51.89M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 18.68M |
| Edwards Lifesciences Corp. | 280.70M |
| Intuitive Surgical, Inc. | 329.40M |
| Stryker Corp. | 398.00M |
| iRhythm Holdings, Inc. | 21.03M |